The Cooper Companies, Inc
- 取引所
- 米国株
- 国 / 地域
- USA
- 上場日
- 1983年12月30日
- 従業員数
- 15,000
- 公式サイト
- www.coopercos.com
総合バリュエーションレンジ · 保守的 $42–$50 / 妥当 $50–$60 / 楽観的 $60–$70。$65.91 時点で 楽観的な本源的価値レンジ内 · 多くの期待を織り込み済み。
レポート公開時 $62.55(2026年5月24日)
この銘柄のレポートはお使いの言語でまだありません。
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
データ提供:EODHD、報告通貨で表示。参考情報であり、投資助言ではありません。
沿革
近日公開このセクションは現在準備中です。近日公開予定です。
業界での地位
近日公開このセクションは現在準備中です。近日公開予定です。
